Skip to main content
Aptus Pharma Limited logo

Aptus Pharma Limited — Investor Relations & Filings

Ticker · 544529 ISIN · INE15XJ01010 LEI · 335800S67NKXF1BKVL66 BSE.NS Manufacturing
Open in API
Filings indexed 11 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS 544529

About Aptus Pharma Limited

https://aptus-pharma.com/

Aptus Pharma Limited specializes in the development, manufacturing, and commercialization of a broad portfolio of pharmaceutical formulations. The company focuses on key therapeutic areas such as cardiovascular health, metabolic disorders, and gastrointestinal treatments. Its operational framework integrates advanced manufacturing technologies with stringent quality assurance protocols to ensure the production of high-standard medicinal products. The product range typically includes solid dosage forms like tablets and capsules, alongside liquid formulations. By prioritizing research and development, the organization seeks to provide effective and accessible therapeutic solutions tailored to diverse clinical requirements.

Recent filings

Filing Released Lang Actions
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015: Brand Promotion Initiative at Rajkot Hirasar Airport
Regulatory Filings Classification · 85% confidence The document is an exchange filing to BSE under SEBI LODR Regulation 30 disclosing a brand promotion initiative. It is a routine regulatory disclosure announcing a material event rather than presenting financial results, management changes, or specific report content. It does not constitute an AGM presentation, earnings release, share issue, or any of the more specific categories. Therefore, it falls into the general “Regulatory Filings” category (RNS).
2026-05-22 English
Disclosure as per Regulation 7 (2) of SEBI (PIT) Regulations, 2015
Director's Dealing Classification · 91% confidence The document is a formal SEBI (PIT Regulations) disclosure on Form C of share transactions by promoters and insiders (buy/sale of equity shares) submitted to the stock exchange. This is an insider trading disclosure of personal share dealings by company directors/promoters. It therefore matches the “Director’s Dealing” category (insider trades), code DIRS.
2026-05-15 English
The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kripaliben Mayank Thakker
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 (Regulation 29) providing detailed tables of share purchase percentages by a promoter group. This is not a company report nor a dividend or earnings release but a mandatory notification of a change in significant shareholding (crossing reporting thresholds). Therefore, it aligns with the “Major Shareholding Notification” category.
2026-05-14 English
The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kunjal Unadkat
Major Shareholding Notification Classification · 85% confidence The text is a formal disclosure under SEBI (SAST) Regulation 29 regarding the substantial acquisition of shares by a promoter, detailing pre- and post-transaction shareholdings. This matches our definition for Major Shareholding Notification (MRQ).
2026-05-14 English
The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Riddhish Natwarlal Tanna
Major Shareholding Notification Classification · 92% confidence The document is a formal disclosure under Regulation 29 of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, filed with BSE. It details the acquisition of equity shares by a promoter, including percentage holdings before and after the transaction. This matches our definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. It is neither an RNS fallback nor a simple report announcement but a direct shareholding change disclosure.
2026-05-14 English
The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Milly Chetan Lalseta
Major Shareholding Notification Classification · 90% confidence The document is a formal SEBI Regulation 29 disclosure detailing the acquisition of equity shares by a promoter (substantial acquisition of shares and takeover) including before‐and‐after shareholding percentages. This matches a Major Shareholding Notification under SEBI (threshold crossing) requirements. Therefore, it is classified as MRQ.
2026-05-14 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.